glp 1 agonist depression Frontiers Ozempic and other GLP-1 drugs

Mean weight loss induced by semaglutide and tirzepatide in obese but nondiabetic individuals

Mounjaro is a once-weekly injection containing tirzepatide, which targets two hormones, GLP-1 and GIP , and it's shown the strongest average weight loss results in clinical trials, at around 22.5% over 72 weeks

A.TrindadeT

Clinical Benefits Beyond Diabetes Management Emerging evidence has revealed that GLP-1 receptor agonists confer significant cardiovascular benefits , extending their therapeutic value beyond glucose control and weight management

It is a question increasingly asked as interest in novel weight-management and hormone-optimising compounds grows, but the answer is far from straightforward